Jim McCamant
Jim McCamant
buy discovery hear rule scientific start stock
The one rule I think is really important when you hear about a scientific discovery is don't buy any stock then -- but you may want to start investigating the company,
clinical favor finally gene later point products stage therapy
Gene therapy has been out of favor but we're finally getting to the point where the products are in later stage clinical trials.
clinical risks seen
There's always risks when you haven't seen the clinical data.
competition market products time
There will be a lot of competition out there by the time these products get to market -- if they do.
ahead larger love
They would love to have the colorectal go ahead because that's a larger market,
stocks window
The IPO window for biotech stocks is closing.
ahead almost difficult fda gotten problem
I think it's probably almost 50-50 the FDA says, 'go ahead and give us the documentation for filing,' ... The problem is that historically the FDA's always gotten more difficult in these cases.
absolutely publicity response slow wrong
My sense is that the FDA's response to all this publicity is to slow down and be even more careful. And that's absolutely the wrong thing to do.
companies decided difficult happened people period raise window
What happened is we went through a long period that was very difficult for biotech companies to raise money. Once this window opened, a lot of people decided that they would go ahead.
below cash cheap stocks trading value
There are stocks that are so cheap and many of them are trading below their cash value.